EFPIA announces position against EMA draft policy

Pharmalive.com’s Ed Silverman reports that in another attempt to stop the European Medicines Agency (EMA) from continuing with their new policy for trial data disclosure, the European Federation of Pharmaceutical Industries and Associations (EFPIA) has openly...

Tufts releases report on causes of drug development failures

On September 10, 2013, the Tufts Center for the Study of Drug Development released a report concerning the leading causes of failures in drug development. Based on a study of products that entered clinical development from 2000 through 2009, the study found that Phase...

Pearl IRB website receives a facelift

The Pearl IRB has undergone changes in design and functionality as well as content. You will quickly notice the new, updated design of the homepage, as well as several other content changes. Summary of changes: New homepage design Easy to use icons on homepage with...

Pearl Pathways will be attending 2013 Site Solutions Summit

Pearl Pathways will be joining more than 500 clinical executives making the commitment to research site success at the 2013 Site Solutions Summit. Hosted by the Society for Clinical Research Sites, the Summit provides 3 days of networking and takeaways designed to...